Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Copyright Notice

Pfizer SWOT

Pfizer—a SWOT Analysis

*****

Pfizer is one of the world's leading research pharmaceutical companies and also one of the ***** most pr*****itable companies. It has a well-respected name known all over the world and commands some of ***** top *****, advert*****ing, financial, and marketing talent. It produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even ***** American Heart Association recommends the use of drugs such as Lipitor to reduce cholesterol when diet and exercise fail ***** reduce this common health problem. High ***** as a common health problem is only likely to *****cre*****e with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

*****

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied ***** Lipitor" which is dangerous for the company in the future as Lipitor's patent will expire ***** several years, ***** means it will face competition from cheaper, generic drugs (Berenson, 2007). Pfizer's reputation has ***** been tainted by ***** association ***** Celebrex, a p*****in medication that has been tied to increased risk of heart *****s, in comparison to over-the-counter painkillers. The prominence of the Pfizer advertising campaign for ***** drug, followed by its rapid f***** *****rom grace undoubtedly damaged the company's trusted name.

***** also manufactures Zoloft, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing ***** suicidal thoughts in this population. ***** company website now states that the drug is not advised for people under the age of 17. Antidepressants and 'lifestyle' drugs like Viagra have come ***** increased media scrutiny and used as examples of the over-prescription of ***** in the American healthcare system ***** general. Healthcare in America is grow*****g more and more expensive, and insurance companies are being pressured ***** cut costs, including scaling back how much they pay for *****.

Now, Exubera, "the first ***** so far ***** commercially available inhaled-insulin diabetes treatment," ***** on the verge of turning into an "expensive failure" as Pfizer "has been dogged by questions about ***** safety, cost and convenience" (Berenson, 2007).

*****

According to the Pfizer press release section of its website, discomfort associated with fibromyaglia, a ***** chronic pain condition, has ***** s*****n to be significantly reduced by a new drug developed by Pfizer called Lyrica, "according to study results presented today at the ***** Academy of Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer ***** also developed a new AIDS ***** called Maraviroc, which is likely to considerably improve and extend the life ***** AIDS p*****ients who take the drug, ***** ***** researchers at ***** University of Pittsburg and Columbia University (Altman & Pollock, 2007).

Threats

***** Merck and Schering-Plough, two ***** Pfizer's greatest rivals, plan to combine forces ***** develop a medicine to rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in ***** ways, could hit the market when Lipi*****r's patent expires in a few years" ("Merck and Scher*****g-Plough Plan Another Cholesterol Drug,"

. . . . [END OF ESSAY PREVIEW]

Download complete paper (and others like it)    |    Order a brand new, custom-written paper

© 2001–2017   |   Book Reports about Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Term Papers Writing